These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28292996)

  • 1. [A Case of Resected Advanced Esophageal Cancer That Responded to Combination Therapy Comprising Docetaxel, Cisplatin, and 5-Fluorouracil].
    Kuga Y; Kitamura S; Mouri T; Miwata T; Sakimoto H; Nishida T
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):247-249. PubMed ID: 28292996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Resected Esophageal Endocrine Cell Carcinoma That Responded to Combination Therapy Comprising Irinotecan and Cisplatin].
    Kuga Y; Kitamura S; Mouri T; Miwata T; Sakimoto H; Nishida T
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):455-458. PubMed ID: 29650904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathological Complete Response in a Case of Advanced Esophageal Cancer with Widespread Lymph Node Metastases Treated Using Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-FU(DCF therapy)].
    Noro H; Hirao T; Takaichi S; Son C; Iwamoto K; Kono E; Yasumasa K; Mizuno H; Morimoto Y; Hatanaka N; Yamasaki Y
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2178-2180. PubMed ID: 28133261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Advanced Esophageal Cancer Successfully Treated with DCF Chemotherapy Followed by Conversion Surgery].
    Okada K; Takeoka T; Miki H; Kobayashi K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1623-1625. PubMed ID: 29394722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].
    Katsumi C; Bamba T; Nakagawa S; Aizawa M; Matsuki A; Yabusaki H; Homma K
    Gan To Kagaku Ryoho; 2017 Jan; 44(1):75-78. PubMed ID: 28174385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological complete response in a case of advanced esophageal cancer invading aorta treated by preoperative chemotherapy with docetaxel and cisplatin plus 5-FU].
    Nishino T; Yamamoto Y; Ikeda M; Morimoto M; Furukawa T; Goto M; Furukita Y; Takechi H; Seike J; Tangoku A; Fujiwara H
    Gan To Kagaku Ryoho; 2013 May; 40(5):643-6. PubMed ID: 23863591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
    Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of a patient with stage IVa esophageal cancer surviving over 4 years by combination chemotherapy with docetaxel,5 -FU and cisplatin, without operation].
    Yamamoto Y; Ikeda M; Takashima M; Minato T; Furukita Y; Takechi H; Seike J; Tangoku A
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1321-4. PubMed ID: 21829072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of esophageal cancer with multiple lymph node metastases which responded to neoadjuvant chemotherapy (DCF therapy).
    Shimakawa T; Naritaka Y; Asaka S; Isohata N; Yamaguchi K; Murayama M; Konno S; Katsube T; Ogawa K; Ide H
    Anticancer Res; 2010 Jan; 30(1):221-6. PubMed ID: 20150639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful Treatment of Advanced Esophageal Cancer with DCF Chemotherapy and Pegfilgrastim].
    Gunjigake K; Okamoto K; Gabata R; Yamaguchi T; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):61-63. PubMed ID: 30765644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of preoperative chemotherapy using docetaxel, cisplatin and fluorouracil with cisplatin and fluorouracil in patients with advanced carcinoma of the thoracic esophagus.
    Ui T; Fujii H; Hosoya Y; Nagase M; Mieno MN; Mori M; Zuiki T; Saito S; Kurashina K; Haruta H; Matsumoto S; Niki T; Lefor A; Yasuda Y
    Dis Esophagus; 2015; 28(2):180-7. PubMed ID: 24529073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma.
    Tanaka Y; Yoshida K; Yamada A; Tanahashi T; Okumura N; Matsuhashi N; Yamaguchi K; Miyazaki T
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1143-52. PubMed ID: 26896963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.
    Nakajima M; Muroi H; Kikuchi M; Takahashi M; Ihara K; Shida Y; Kurayama E; Ogata H; Yamaguchi S; Sasaki K; Sakai M; Sohda M; Miyazaki T; Kuwano H; Kato H
    Anticancer Res; 2018 Feb; 38(2):911-918. PubMed ID: 29374720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of neoadjuvant chemotherapy for advanced esophageal cancer].
    Tanabe S; Shirakawa Y; Maeda N; Katsube R; Ohara T; Sakurama K; Noma K; Fujiwara T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1612-4. PubMed ID: 24393865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.
    Ajani JA; Fodor MB; Tjulandin SA; Moiseyenko VM; Chao Y; Cabral Filho S; Majlis A; Assadourian S; Van Cutsem E
    J Clin Oncol; 2005 Aug; 23(24):5660-7. PubMed ID: 16110025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal Carcinoma.
    Satomura H; Nakajima M; Sasaki K; Yamaguchi S; Domeki Y; Takahashi M; Muroi H; Kubo T; Kikuchi M; Otomo H; Ihara K; Kato H
    Int Surg; 2015 Jun; 100(6):1153-8. PubMed ID: 26414837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of efficacy and safety of first-line docetaxel/cisplatin/5-FU combined therapy for advanced esophageal cancer].
    Minowa M; Kinoshita Y; Hasebe S; Ito T; Ogawa M; Takebayashi K; Ehara K; Ueno M; Udagawa H; Hayashi M
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):393-7. PubMed ID: 21403440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CR of All Target Lesions in a Patient with Metastatic Esophageal Cancer and Generalized Weakness Treated with Systemic Chemotherapy after Nutritional Support].
    Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2000-2003. PubMed ID: 28133202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Advanced Esophageal Cancer Successfully Treated with Neoadjuvant Chemotherapy Containing 5-FU, Docetaxel. and Nedaplatin Combination Therapy].
    Kimura Y; Shiraishi O; Kawakami H; Ueda H; Okuno T; Hiraki Y; Kato H; Iwama M; Yasuda A; Shinkai M; Chikugo T; Imano M; Imamoto H; Nakagawa K; Yasuda T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1812-1814. PubMed ID: 30692362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
    Ajani JA; Moiseyenko VM; Tjulandin S; Majlis A; Constenla M; Boni C; Rodrigues A; Fodor M; Chao Y; Voznyi E; Awad L; Van Cutsem E;
    J Clin Oncol; 2007 Aug; 25(22):3210-6. PubMed ID: 17664468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.